• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Intensified therapy of severe lupus erythematosus].

作者信息

Euler H H, Schröder J O, Gutschmidt H J, Harten P, Stueber F, Zeuner R A, Löffler H

机构信息

II. Medizinische Klinik und Poliklinik, Universität sowie Abteilung für Intensivmedizin und Dialyse, Städtisches Krankenhaus, Kiel.

出版信息

Dtsch Med Wochenschr. 1991 Jul 12;116(28-29):1081-8. doi: 10.1055/s-2008-1063720.

DOI:10.1055/s-2008-1063720
PMID:2065594
Abstract

14 female patients (mean age 28 [18-56] years) with severe systemic lupus erythematosus (SLE) were treated after discontinuing previous immunosuppressive therapy, according to an intensified protocol, with three plasmaphereses (days 1-3), followed by pulse cyclophosphamide (12 mg/kg i.v. each on days 3-5) and then oral immunosuppression (cyclophosphamide 1-5 mg/kg daily, depending on white blood cell count; prednisone equivalent 2.0 decreasing to 0.1 mg/kg, according to response, for 6 months). The aim of "synchronization" of plasmaphereses with subsequent cyclophosphamide pulse-therapy is to damage pathogenic lymphocyte clones during maximal compensatory activation induced by plasmapheresis. In all patients there was rapid improvement from the nephritis, pneumonitis, cytopenia, CNS abnormalities and polyserositis. The lupus activity index (SLAM) fell clearly, from initially 28.4 (13-37) points to 8.9 (2-13) after 6 months. Treatment was discontinued after this fall in 12 patients. A recurrence was observed in two patients, at 12 and 39 months respectively. Another patient died from liver cirrhosis of unknown aetiology. Nine patients are under observation but without treatment at present, in essential remission after 2 years (5-51 months), with a SLAM of 2.8 (0-7) points. "Synchronization" of plasmaphereses with subsequent pulse cyclophosphamide achieved rapid improvement and it resulted, for the first time, repeatedly in long-term treatment-free clinical remissions.

摘要

相似文献

1
[Intensified therapy of severe lupus erythematosus].
Dtsch Med Wochenschr. 1991 Jul 12;116(28-29):1081-8. doi: 10.1055/s-2008-1063720.
2
Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
Ann Med Interne (Paris). 1994;145(5):296-302.
3
[Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].[血浆置换和环磷酰胺同步治疗伴肾脏受累的快速进展性系统性红斑狼疮]
Ter Arkh. 1996;68(5):27-30.
4
[Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].[不同环磷酰胺治疗方案对狼疮性肾炎病程及预后的比较]
Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:19-25.
5
Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.同步治疗与大剂量环磷酰胺治疗增殖性狼疮性肾炎
J Clin Apher. 2002;17(2):72-7. doi: 10.1002/jca.10020.
6
High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.系统性红斑狼疮中不进行干细胞移植的大剂量环磷酰胺治疗
Arthritis Rheum. 2003 Jan;48(1):166-73. doi: 10.1002/art.10752.
7
[Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].[静脉输注环磷酰胺治疗急性系统性红斑狼疮。价值与局限性]
Ann Med Interne (Paris). 1994;145(2):75-87.
8
Immunosuppressive treatment of the glomerulonephritis of systemic lupus.系统性红斑狼疮性肾小球肾炎的免疫抑制治疗
Clin Nephrol. 1995 Dec;44(6):367-75.
9
Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.系统性红斑狼疮的门诊每月口服大剂量环磷酰胺治疗
J Rheumatol. 1996 Feb;23(2):273-8.
10
Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report.地塞米松环磷酰胺脉冲疗法治疗系统性红斑狼疮:一例报告
J Dermatolog Treat. 2009;20(1):55-8. doi: 10.1080/09546630802155065.